Blood, Sweat & Stem Cells: Scaling a Longevity Empire After the NFL

What if your health routine mattered more than your hustle? Jimmy St. Louis traded shoulder pads for stem cells…and he’s building a business that could outlive us all.

In this episode, Matt and Luigi sit down with Jimmy St. Louis (former NFL player, serial entrepreneur, and CEO of Agentis Longevity) to talk about the future of healthcare that doesn’t start in a waiting room. From biohacking to business strategy, Jimmy breaks down how he’s turning the longevity space into a movement; accessible, affordable, and built for people who actually live in the real world (no ice baths required).

 

What we’re covering:

• Why true longevity starts with understanding your own damn body

• The difference between hormone therapy and doping (yes, there’s a line)

• What private equity actually looks like behind the scenes

• The “rest, recover, repeat” rule that applies to business and life

• How Jimmy grew a med-tech company from 9 to thousands of employees

• Biohacks that aren’t just for billionaires…or Brian Johnson wannabes

• Why his daughter is already smarter about EMFs than most adults

 

Who is Jimmy? 

Jimmy St. Louis is a former Tennessee Titans tight end, U.S. National Rower, multi-exit entrepreneur, and current CEO of Agentis Longevity, a healthcare platform redefining how everyday people access elite-level health optimization.

 

Favorite Quote:

"If you add something new to your lifestyle, something else has to change."

 

Take Action:

Want to know what NFL grit, Wall Street brains, and regenerative medicine have in common? Tune in now to find out; this episode is a game-changer for anyone serious about playing the long game in business and health.

 

Connect with Jimmy:

• Website

• LinkedIn

 

Like what you heard? Don’t forget to subscribe, rate, and review!

🎧  Listen (or watch) The Liquid Lunch Project on all major platforms, including:

• Our website

• Apple Podcasts 

• Spotify 

• Audible 

• YouTube 

 

📧 Want even more? Subscribe to The Weekly, our Friday morning newsletter, for all the latest in the world of finance, tech, small business, and more. 

.css-j9qmi7{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;font-weight:700;margin-bottom:1rem;margin-top:2.8rem;width:100%;-webkit-box-pack:start;-ms-flex-pack:start;-webkit-justify-content:start;justify-content:start;padding-left:5rem;}@media only screen and (max-width: 599px){.css-j9qmi7{padding-left:0;-webkit-box-pack:center;-ms-flex-pack:center;-webkit-justify-content:center;justify-content:center;}}.css-j9qmi7 svg{fill:#27292D;}.css-j9qmi7 .eagfbvw0{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;color:#27292D;}